ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
8.93
+0.19 (2.17%)
Nov 21, 2024, 1:56 PM EST - Market open

ORIC Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
6305022655791,240-
Upgrade
Market Cap Growth
119.16%89.55%-54.26%-53.32%--
Upgrade
Enterprise Value
354285843021,053-
Upgrade
Last Close Price
8.749.205.8914.7033.85-
Upgrade
PB Ratio
2.252.241.192.124.28-
Upgrade
P/TBV Ratio
2.642.241.192.124.28-
Upgrade
Debt / Equity Ratio
0.040.050.050.05--
Upgrade
Quick Ratio
12.8210.1813.4015.6432.6116.65
Upgrade
Current Ratio
13.1510.3913.6815.8732.9616.81
Upgrade
Return on Equity (ROE)
-45.98%-45.11%-35.99%-27.98%-39.02%-41.10%
Upgrade
Return on Assets (ROA)
-29.22%-27.74%-19.87%-16.50%-15.69%-25.36%
Upgrade
Return on Capital (ROIC)
-31.07%-29.54%-20.86%-17.14%-16.33%-27.30%
Upgrade
Earnings Yield
-19.55%-20.06%-33.66%-13.60%-5.94%-
Upgrade
FCF Yield
-17.92%-17.24%-29.16%-10.45%-3.70%-
Upgrade
Buyback Yield / Dilution
-41.07%-29.75%-4.48%-72.97%-1055.26%-9.53%
Upgrade
Total Shareholder Return
-41.07%-29.75%-4.48%-72.97%-1055.26%-9.53%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.